Residual Host dPCR

Quantitation of residual host cell DNA levels using digital PCR technology to determine the host cell impurities in target samples (in-process, final product, etc.), supporting the risk assessment and regulatory compliance of biological products.

Quantitative Residual Host Cell DNA testing using digital PCR technology

What is this service?

Contamination of residual host cell DNA in biological products poses the potential risks to the patients. To ensure the safety and regulatory compliance of biological products, BaseClear provides the phase-appropriate analytical testing service to monitor and quantify the residual host DNA in a broad range of samples containing different matrix compositions derived from several producer cell species (e.g. HEK, E.coli, CHO, Vero, Sf9). We also offer expert consultation and custom project design to ensure high-quality data delivery and optimal solutions tailored to the client’s specific requirement. 

Who is it for?

Residual host cell DNA testing in biological products from biopharmaceutical/biotechnology sectors for:

  1. Monitoring the host cell impurity level in different manufacturing stages of biological products
  2. Building the data package according to phase-appropriate CMC requirements for regulatory submission.
  3. Quality Control routine testing for batch release

Methodology

Residual host cell DNA in the biological samples is detected and quantitated using QIAcuity digital PCR technology, which relies on the absolute quantitation of the target DNA concentration using sample partitioning method in a microfluidic nanoplate system. Due to the endpoint quantitation without the need of standard curves, the assay is less susceptible to PCR inhibitors and amplification biases, increasing assay precision and providing the advantage over the quantitative PCR (qPCR) assay.

We offer an extraction-free residual host cell DNA quantitation directly in the target samples, circumventing the need of additional custom sample extraction optimization with different sample compositions and providing more simplified analytical workflow.

Our residual host cell DNA testing platform was developed and pre-validated in the common representative biological samples according to ICH Q2 guideline. This is to demonstrate that the method is fit-for-purpose to measure the residual host cell DNA in these typical biological matrixes, providing an early insight into the overall fit-for-purpose assay performance to our clients.

What you receive

Deliverables:

  • Study and testing reports with analyzed data package
  • Original raw data
  • (Optional, upon project request) regulatory/CMC document data package preparation according to client’s specific requirement/input

How it works:
Your path to high-quality residual host cell DNA testing

Step 1

Step Title

Contact us & Free consultation with BaseClear expert team for specific project requirement 

Step 2

Step Title

Project-specific quotation according to service scope: 

  • Phase- appropriate biological sample testing according to the client’s development/commercial stage (e.g., non-clinical, early/late clinical stage, commercial) 
  • Fit-for purpose method evaluation (non-qualification, qualification, validation) 
  • Number of sample types (matrix) to be evaluated prior to routine testing 
  • Number of sample per type (matrix) to be tested in the routine testing 
  • Safety consideration of products (BSL-1, BSL-2) 
  • Additional specific requests 
  • Etc. 

 

Step 3

Step title

Fit-for-purpose evaluation of method performance in client’s samples containing specific matrix composition:

Protocol drafting by BaseClear team

Protocol reviewing by clients

Protocol revision by BaseClear team with client’s input

Protocol approval by BaseCear team and clients

Sample submission by clients

Study execution, analysis, and internal data quality review by BaseClear team

Tailored study/testing report drafting by BaseClear and report reviewing by clients

Study report revision by BaseClear with client’s input

Final study report and data package provided to clients.

Confirmation of fit-for-purpose method performance status, supporting routine testing of client’s samples.

Step 4

Step title

(Optional) Routine testing of the client’s samples:

Testing protocol drafting by BaseClear and protocol reviewing by clients.

Testing protocol revision by BaseClear with client’s input.

Execution of testing protocol by BaseClear.

Testing report drafting by BaseClear and report reviewing by clients.

Testing report revision by BaseClear with client’s input.

Final testing report and data package provided to clients.

Trusted expertise in DNA sequencing and cell line quality control

CONEXTUALIZED
XX+

Genomics and sequencing projects completed

REGULATORY-DRIVEN
XX+

Years of sequencing and genomics expertise

FLEXIBLE
XX+

Validated molecular analysis workflows

TARGETED
XX+

Cell culture samples analysed

Resources on cell line authentication and species identification

ARTICLE

Cell line authentication: a necessity for reproducible biomedical research

Learn how cell line misidentification affects research reproducibility and why authentication is critical for reliable results.
ARTICLE

Species identification in cell culture: a two-pronged molecular approach

Peer-reviewed study demonstrating the use of mitochondrial DNA barcoding and COI sequencing to accurately identify cell line species and detect cross-contamination in cell culture systems.
ARTICLE

Biological identifications through DNA barcodes

Landmark scientific paper introducing DNA barcoding and demonstrating how sequencing the mitochondrial cytochrome c oxidase I (COI) gene enables reliable species identification across animal taxa.

Technical questions about antimicrobial activity testing

What is cell line species identification?

Cell line species identification determines the biological species from which cultured cells originate using genetic analysis. This verification ensures that cell lines used in research or production correspond to the expected organism and are not contaminated by cells from another species.

Species identification is important because misidentified cell lines can compromise experimental reproducibility, research credibility, and regulatory documentation. Confirming species origin ensures that cell cultures accurately represent the intended biological model.

The mitochondrial cytochrome c oxidase subunit I (COI) gene is widely used for DNA barcoding because it shows strong sequence variation between species while remaining relatively conserved within species. This makes it a reliable genetic marker for species-level identification.

COI sequencing can detect cross-species contamination by revealing whether the genetic sequence corresponds to a different species than expected. This helps identify cases where cell cultures may have been contaminated with cells from another organism.

STR profiling is typically used to authenticate human cell lines, whereas COI sequencing determines the species origin of animal cell lines. Both methods are complementary and may be used together in comprehensive cell line quality control programs.

Species identification is recommended when establishing cell banks, acquiring new cell lines, or performing routine quality control of cell culture systems. Early verification helps prevent costly downstream issues caused by misidentified cell lines. 

Explore related services

SERVICES

Mycoplasma GMP testing

Detect mycoplasma contamination in cell cultures using sensitive molecular detection methods.

SERVICES

Sanger Sequencing

High-accuracy DNA sequencing for PCR products, plasmids, and targeted genetic regions.

SERVICES

Residual host cell DNA quantification

Quantify the residual host cell DNA in your samples using digital PCR technology.

Talk to our scientist

Speak with our experts to discuss your cell line identification project. We will help you determine the appropriate analysis approach and provide reliable sequencing results to support your research and quality control workflows.

Contact us